Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             331 results found
no title author magazine year volume issue page(s) type
1 Accuracy and validity of sentinel lymph node biopsy for breast cancer by using photosensitizer Yamada, K.
 2011
 8 2 p. 204-
1 p.
 article
2 ALA and its impact on PDD/PDT Kennedy, J.
 2011
 8 2 p. 123-
1 p.
 article
3 ALA dendrimers to improve diagnostic of fluorescence cystoscopy of bladder cancer Francois, A.
 2011
 8 2 p. 175-
1 p.
 article
4 5-ALA-induced PPIX fluorescence in intramedullary tumors Zelenkov, P.
 2011
 8 2 p. 163-
1 p.
 article
5 5-ALA induced protoporphyrin IX synthesis and responsiveness to photodynamic therapy in meningioma cells Hefti, M.
 2011
 8 2 p. 211-212
2 p.
 article
6 5-ALA supported resection of glioblastoma in a multimodality therapeutic concept; a single-center experience of a series of 106 patients Richling, B.
 2011
 8 2 p. 165-
1 p.
 article
7 5-Aminolevulinic acid induced photodynamic therapy in migratory glioma cells Albert, I.
 2011
 8 2 p. 166-
1 p.
 article
8 Amplification of PDT-induced cancer cell apoptosis by adjuvant sphingolipid mediators Mladen Korbelik1 and Duska Separovic2 Korbelik, M.
 2011
 8 2 p. 127-
1 p.
 article
9 Analysis of surviving cells in breast cancer after photodynamic therapy Ferreira, Juliana
 2011
 8 2 p. 138-
1 p.
 article
10 Analysis of the feasibility of the use of white LED and Photogem® in photodynamic therapy Requena, M.B.
 2011
 8 2 p. 198-199
2 p.
 article
11 A new 5-ALA-patch for the photodynamic therapy of actinic keratoses Szeimies, R.-M.
 2011
 8 2 p. 200-
1 p.
 article
12 A new device for hexaminolevulinate (HAL) photodynamic therapy (PDT) in patients with cervical HPV and precancer Soergel, P.
 2011
 8 2 p. 149-150
2 p.
 article
13 A new type of LD 3 wavelength pulsed laser for PDD and PDT Miyoshi, N.
 2011
 8 2 p. 142-
1 p.
 article
14 An investigation of the fluorescence induced by topical application of 5-aminolaevulinic acid and methyl aminolaevulinate at different body sites on normal human skin Lesar, Andrea
 2011
 8 2 p. 97-103
7 p.
 article
15 An optical-tip anti-charring system for photodynamic-therapy laser irradiation in blood via a catheter Takahashi, M.
 2011
 8 2 p. 197-
1 p.
 article
16 A novel finished formulation of the photosensitizer Photolon® for topical application. Evaluation of the efficacy in patients with basal-cell carcinoma of the skin Trukhachova, T.V.
 2011
 8 2 p. 200-201
2 p.
 article
17 A novel mutual prodrug-induced, and quantitatively and selectively enhanced PpIX accumulation in brain tumors Mai, Z.
 2011
 8 2 p. 212-
1 p.
 article
18 Antimicrobial effects of azulene induced by light Baptista, Alessandra
 2011
 8 2 p. 179-180
2 p.
 article
19 Antimicrobial PDT: Strategies for optimization and prospective applications in clinic and environment Jori, G.
 2011
 8 2 p. 124-
1 p.
 article
20 Antimicrobial photodynamic therapy: Can resistance develop? Hamblin, M.
 2011
 8 2 p. 178-
1 p.
 article
21 Antimicrobial photodynamic therapy in Candida albicans induced-vaginitis: A murine model study for localized infection Ribeiro, M.
 2011
 8 2 p. 171-
1 p.
 article
22 Antimicrobial photodynamic therapy in treatment of aggressive periodontitis Loebel, N.
 2011
 8 2 p. 182-
1 p.
 article
23 Antimicrobial photodynamic treatment—A helpful approach in immunocompromised patients Maisch, Tim
 2011
 8 2 p. 178-
1 p.
 article
24 Antivascular versus anticellular PDT. A proton and sodium MRI follow-up of human colorectal tumors implanted in mice Lupu, M.
 2011
 8 2 p. 130-131
2 p.
 article
25 Antiviral and antimycotic effects of PDT with ALAsense Apolikhina, I.A.
 2011
 8 2 p. 170-171
2 p.
 article
26 Apoptotic biomarker of topical photosan-mediated photodynamic therapy on DMBA-induced hamster buccal pouch precancerous lesions Hsu, Y.-C.
 2011
 8 2 p. 214-
1 p.
 article
27 Apoptotic induction by photodynamic therapy with porphyrin precursors in tumour cells Peng, Q.
 2011
 8 2 p. 148-
1 p.
 article
28 Application of differential pathlength spectroscopy in head and neck optical diagnostics Witjes, M.
 2011
 8 2 p. 148-
1 p.
 article
29 Are 2 photons better than 1? Wilson, B.
 2011
 8 2 p. 142-
1 p.
 article
30 Assessment of quality of life in patients undergoing photodynamic therapy Jerjes, W.
 2011
 8 2 p. 214-
1 p.
 article
31 A systematic review of photodynamic therapy for high grade gliomas Phang, Isaac
 2011
 8 2 p. 124-125
2 p.
 article
32 A theoretical fluence rate profile model to design a spiral, spatially optimized fiber optic blanket for intra-operative photodynamic therapy Kundu, P.
 2011
 8 2 p. 198-
1 p.
 article
33 Author Index 2011
 8 2 p. 107-122
16 p.
 article
34 Bactericidal effect of photodynamic therapy with Indocyanine Green on Staphylococcus aureus Topaloglu, N.
 2011
 8 2 p. 220-221
2 p.
 article
35 Basic photochemical mechanisms in FD and PDT Stepp, H.
 2011
 8 2 p. 126-
1 p.
 article
36 Being the advocatus diaboli: Photodynamic therapy to combat Tasmanian devil facial tumors Maake, C.
 2011
 8 2 p. 139-
1 p.
 article
37 Biological activity and photophysical properties of novel chlorin-based photosensitizers Rams-Baron, M.
 2011
 8 2 p. 189-
1 p.
 article
38 Black tattoo inks in skin—A hazardous chemical cocktail? Lehner, K.
 2011
 8 2 p. 201-
1 p.
 article
39 Boronation of tetrapyrrolic compounds: Novel chemistry for improved photodynamic potency Ol'shevskaya, V.
 2011
 8 2 p. 134-135
2 p.
 article
40 Carbohydrate-conjugated porphyrin oligomers for two photon photodynamic therapy: Synthesis and photobiological evaluation Garcia, G.
 2011
 8 2 p. 189-190
2 p.
 article
41 Cellular and molecular effects of the liposomal mTHPC derivative Foslipos in prostate carcinoma cells in vitro Gyenge, Emina Besic
 2011
 8 2 p. 86-96
11 p.
 article
42 Cellular phenotype and photosensitiser uptake as determinants of the efficiency of photodynamic therapy (PDT) for biliary tract cancer Kiesslich, T.
 2011
 8 2 p. 219-
1 p.
 article
43 Cellulose nanocrystals: A new chlorin carrier designed for photodynamic therapy: Synthesis, characterization and potent anti-tumoural activity Drogat, N.
 2011
 8 2 p. 157-
1 p.
 article
44 Challenges in clinical PDT Moghissi, Keyvan
 2011
 8 2 p. 73-74
2 p.
 article
45 Chitosan augments photodynamic inactivation of Candida Chien, H.-F.
 2011
 8 2 p. 180-
1 p.
 article
46 Clinical application of an IR navigation system for pleural PDT Zhu, T.
 2011
 8 2 p. 141-
1 p.
 article
47 Clinical attachment level (CAL) gain in periodontics using photodynamic therapy as adjunct treatment Giusti, J.S.M.
 2011
 8 2 p. 180-181
2 p.
 article
48 Clinical observation of early laryngeal cancer photodynamic therapy Li, L.
 2011
 8 2 p. 227-
1 p.
 article
49 Clinical standards in photodynamic diagnosis and therapy Siero, A.
 2011
 8 2 p. 160-
1 p.
 article
50 Combination of photodynamic therapy with an antiseptic drug for local antimicrobial therapy Diddens-Tschoeke, H.
 2011
 8 2 p. 180-
1 p.
 article
51 Combination therapy using methotrexate, 5-fluorouracil, and vitamin D as PpIX-elevating agents followed by ALA-PDT of skin tumors: Mechanisms of action Maytin, E.
 2011
 8 2 p. 129-
1 p.
 article
52 Comparative in vitro investigations of photodynamic and photothermal therapies versus chemotherapy for breast cancer treatment Emam Omar Gomaa, I.
 2011
 8 2 p. 216-
1 p.
 article
53 Comparative studies of photophysical and biological properties of hypericin and hypericin-glucamine Bernal, C.
 2011
 8 2 p. 190-
1 p.
 article
54 Comparison of cryotherapy and photodynamic therapy in treatment of oral leukoplakia Kawczyk-Krupka, A.
 2011
 8 2 p. 214-215
2 p.
 article
55 Comparison of photodynamic inactivation of Candida albicans biofilm cells by two distinct porphyrin derivatives and blue light Gonzales, F.
 2011
 8 2 p. 221-
1 p.
 article
56 Comparison of protoporphyrin IX accumulation and photobleaching during methyl-aminolevulinate photodynamic therapy of skin tumours located at acral and non-acral sites Allen, J.
 2011
 8 2 p. 147-
1 p.
 article
57 Complexes of tetrapyrrolic photosensitizers with biomacromolecules: Parameters important for therapeutic efficacy Golovina, G.
 2011
 8 2 p. 190-
1 p.
 article
58 Conception and synthesis of new two-photon photosensitizers for application to photo dynamic therapy (PDT) Hammerer, F.
 2011
 8 2 p. 190-
1 p.
 article
59 Conjugation of targeting peptides to chlorophyll-a based photosensitizer (HPPH) altered its pharmacokinetics with enhanced tumor-imaging and photodynamic therapy Srivatsan, A.
 2011
 8 2 p. 197-
1 p.
 article
60 Contributions of experiment designs in photodynamic therapy: Photosensitizer design, treatment analysis and optimization Bastogne, T.
 2011
 8 2 p. 137-
1 p.
 article
61 Covalently linked photoactive cisplatin conjugates for a combined chemotoxic and photodynamic therapy Spingler, B.
 2011
 8 2 p. 191-
1 p.
 article
62 Curcumin as a photosensitizer: Studies on different cell lines Verwanger, T.
 2011
 8 2 p. 186-
1 p.
 article
63 Delivery strategies for porphyrin precursors Donnelly, R.
 2011
 8 2 p. 144-
1 p.
 article
64 Delivery systems for topical photodynamic antimicrobial chemotherapy Donnelly, R.
 2011
 8 2 p. 179-
1 p.
 article
65 Designing non-ionic phthalocyanines for PDT: Strategies, synthesis and SAR Dumoulin, F.
 2011
 8 2 p. 134-
1 p.
 article
66 Design of smart nanocarriers for photosensitizer delivery Nishiyama, N.
 2011
 8 2 p. 155-156
2 p.
 article
67 Detection of early cancers by endoscopic fluorescence imaging Wagnieres, G.
 2011
 8 2 p. 152-
1 p.
 article
68 Determination of tissue optical properties in ALA-mediated Head & Neck PDT Dimofte, A.
 2011
 8 2 p. 167-168
2 p.
 article
69 Development of high content screening methods for photosensitizer analysis Senge, M.
 2011
 8 2 p. 191-
1 p.
 article
70 Development of the novel intervention therapy for patients with advanced lung cancer in the central airways Ohtani, K.
 2011
 8 2 p. 177-
1 p.
 article
71 Direct and indirect measurements of singlet oxygen: A comparative study Li, B.
 2011
 8 2 p. 141-
1 p.
 article
72 Discovery and development of novel thiaza and thioxa Type 1 photosensitizers Rajagopalan, R.
 2011
 8 2 p. 191-
1 p.
 article
73 Dosimetry: Difficulties of quantifying the ‘amounts’ of singlet oxygen and other ROS in single cell photosensitized experiments Ogilby, P.R.
 2011
 8 2 p. 150-
1 p.
 article
74 Dosimetry for interstitial photodynamic therapy Andersson-Engels, S.
 2011
 8 2 p. 140-
1 p.
 article
75 E-atlas of photodynamic images Kwiatek, S.
 2011
 8 2 p. 160-161
2 p.
 article
76 Editorial Board 2011
 8 2 p. i-
1 p.
 article
77 Effect of high fluence light emitting diode mediated photodynamic therapy with Photofrin II on high-grade solid tumor model Lim, H.-J.
 2011
 8 2 p. 185-
1 p.
 article
78 Effect of Hypericin-PDT using different lamps in U937 cells Nakajima, N.
 2011
 8 2 p. 135-
1 p.
 article
79 Efficacy of the adjuvant intraoperative photodynamic therapy with Photolon® in patients with malignant brain tumors Fedulov, A.S.
 2011
 8 2 p. 164-165
2 p.
 article
80 Efficacy of the novel finished formulation of the photosensitizer Photolon® applied for photodynamic therapy of chronic marginal gingivitis and chronic periodontitis Trukhachova, T.V.
 2011
 8 2 p. 224-225
2 p.
 article
81 Efficiency of chlorine photosensitizers for photodynamic therapy on endobronchial tumors Ragulin, Y.
 2011
 8 2 p. 177-
1 p.
 article
82 Endoscope guided interstitial photodynamic therapy for treatment of recurrent nasopharyngeal carcinoma Sheikh, O.
 2011
 8 2 p. 167-
1 p.
 article
83 Endoscopic intraparenchymal brain tumor biopsy with PDD Zaboronok, A.
 2011
 8 2 p. 162-
1 p.
 article
84 Endothelial cells are involved in the response to topical PpIX-PDT de Bruijn, H.S.
 2011
 8 2 p. 130-
1 p.
 article
85 Enhanced antitumor efficacy in vivo of PEGylated dual-effect liposome containing doxorubicin and Ce6 Chen, C.
 2011
 8 2 p. 204-205
2 p.
 article
86 Enhanced photodynamic therapy using NIR-to-visible upconversion fluorescent nanoparticles Zhang, Y.
 2011
 8 2 p. 158-
1 p.
 article
87 Establishing PDT in mainstream clinical practice Bown, S.
 2011
 8 2 p. 125-
1 p.
 article
88 EtNBS-based photodynamic therapy for the treatment of hypoxic and otherwise therapeutically unresponsive cancer cell populations Park, Y.J.
 2011
 8 2 p. 205-
1 p.
 article
89 Evaluation of a radiosensitizing effect of 5-aminolevlunic acid for malignant gliomas Yamamoto, J.
 2011
 8 2 p. 210-
1 p.
 article
90 Experience with 2-1 [hexyloxyethyl]-2-devinylpyropheophorbide-a] (HPPH) photodynamic therapy in head and neck dysplasia and squamous carcinoma (SCC) Rigual, N.
 2011
 8 2 p. 168-
1 p.
 article
91 Field trials using chlorophyll derivatives with sunlight for malaria and filaria vectors control in Sub-Saharan Africa Abdelkader, M.
 2011
 8 2 p. 180-
1 p.
 article
92 Finding molecular mechanism of response to photodynamic inactivation of bacteria Nakonieczna, J.
 2011
 8 2 p. 221-222
2 p.
 article
93 FLIM and SLIM for autofluorescence and PDD: New algorithms Rueck, A.
 2011
 8 2 p. 123-124
2 p.
 article
94 Fluorescence and reflectance spectroscopy for protoporphyrin IX quantifiaction in tissue-like media Palte, G.
 2011
 8 2 p. 212-
1 p.
 article
95 Fluorescence spectroscopy during ALA/PpIX-mediated PDT of the oral cavity Finlay, J.
 2011
 8 2 p. 168-
1 p.
 article
96 Fluorescent diagnosis: Novel method to detection of metastatic lymph node lesions in patients with breast cancer Filonenko, E.V.
 2011
 8 2 p. 205-
1 p.
 article
97 Fluorescent diagnostics with Alasens in coloproctology Filonenko, E.V.
 2011
 8 2 p. 173-
1 p.
 article
98 Focal treatment of prostate cancer with vascular-targeted photodynamic therapy Mordon, S.
 2011
 8 2 p. 174-
1 p.
 article
99 Folic acid and peptides in targeting strategies Barberi-Heyob, M.
 2011
 8 2 p. 156-157
2 p.
 article
100 Formulation of novel colon specific delivery devices for photodynamic antimicrobial chemotherapy (PACT) Cassidy, C.
 2011
 8 2 p. 181-
1 p.
 article
101 FosPeg®-mediated photocytotoxicity suppresses cancer cell growth through down-regulation of MEK pathways Wu, R.W.K.
 2011
 8 2 p. 188-
1 p.
 article
102 Fractionated ALA-PDT in PAM212 cells de Bruijn, H.S.
 2011
 8 2 p. 203-204
2 p.
 article
103 From cell to patient: Basic photodynamic effects on cells, tissue and animal models Berg, K.
 2011
 8 2 p. 126-
1 p.
 article
104 Functional analysis of Fospeg in photodynamic treatment of hepatocellular carcinoma cell models Sherifa, G.
 2011
 8 2 p. 219-
1 p.
 article
105 Functionalized mesoporous silica nanoparticles for two-photon photodynamic therapy Raehm, L.
 2011
 8 2 p. 159-
1 p.
 article
106 Generation of singlet oxygen by UVB-irradiation of endogenous molecules Regensburger, J.
 2011
 8 2 p. 152-
1 p.
 article
107 Grp78-targeting cytotoxin potentiates Photofrin-PDT in prostate cancer cell lines Firczuk, M.
 2011
 8 2 p. 187-188
2 p.
 article
108 HAL/MAL photodynamic therapy for CIN Hillemanns, P.
 2011
 8 2 p. 169-
1 p.
 article
109 Head and neck squamous cell carcinoma treated with palliative interstitial photodynamic therapy: A review of 40 cases Lee, Y.
 2011
 8 2 p. 167-
1 p.
 article
110 Heme carrier protein 1 involves a cancer specific porphyrin accumulation Matsui, H.
 2011
 8 2 p. 185-186
2 p.
 article
111 Hexaminolevulinate (HAL) photodynamic therapy (PDT) of patients with cervical intraepithelial neoplasia grade 1 (CIN1) Soergel, P.
 2011
 8 2 p. 149-
1 p.
 article
112 Hexvix® mediated rat bladder photodynamic therapy: The impact of fluence rate on normal bladder preservation Salvadori, A.
 2011
 8 2 p. 149-
1 p.
 article
113 Hexyl aminolevulinate and light induces posttranslational modifications of proteins in different cell pathways Gederaas, O.A.
 2011
 8 2 p. 127-128
2 p.
 article
114 High magnification cystoscopy to characterize lesions detected with hexaminolevulinate Kratzer, G.
 2011
 8 2 p. 175-
1 p.
 article
115 Histopathological study of necrosis after PDT using a bacteriochlorin with light absorption spectrum in 749 Rego, R.F.
 2011
 8 2 p. 219-
1 p.
 article
116 History and current situation of PD/PDT with porphyrin precursors Malik, Z.
 2011
 8 2 p. 147-
1 p.
 article
117 How to get regulatory approval of PDT/PD products Horten, A.G.
 2011
 8 2 p. 150-
1 p.
 article
118 Human and veterinary PD and PDT are both improving grace to a common knowledge base in cancer treatment Walt, H.
 2011
 8 2 p. 139-
1 p.
 article
119 Identification of potential targets for enhancing ALA-PDT of tumors Morgan, J.
 2011
 8 2 p. 136-
1 p.
 article
120 Image processing in autofluorescence imaging of prencacerous and cancerous skin changes Kwiatek, S.
 2011
 8 2 p. 203-
1 p.
 article
121 Immobilized metallophthalocyanines and fullerene C60 for inactivation of pathogenic microorganisms Mantareva, V.
 2011
 8 2 p. 181-182
2 p.
 article
122 Immunohistochemistry after HAL/MAL PDT for CIN lesions Soergel, P.
 2011
 8 2 p. 169-
1 p.
 article
123 Improvement of therapeutic effects by laser irradiation technique in photodynamic therapy (PDT) laser system Lim, H.S.
 2011
 8 2 p. 160-
1 p.
 article
124 Improving verterporfin-PDT in pre-clinical pancreas cancer with dosimetry Pogue, B.
 2011
 8 2 p. 140-141
2 p.
 article
125 Increase in drug delivery by ALA-PDT Hirschberg, H.
 2011
 8 2 p. 148-149
2 p.
 article
126 Influence of photodynamic therapy in mammary carcinogenesis Ferreira, I.
 2011
 8 2 p. 186-
1 p.
 article
127 Inhibition of glioma cell growth by photochemical internalization (PCI) enhanced transfection of tumor suppressor genes Hirschberg, H.
 2011
 8 2 p. 165-166
2 p.
 article
128 Innovative engineering design of a textile light diffuser for photodynamic therapy Mordon, S.
 2011
 8 2 p. 142-143
2 p.
 article
129 Intense pulse light and 5-ALA PDT: Phototoxic effects in vitro depend on the spectral overlap with protoporphyrine IX but do not match cut-off filter notations Maisch, T.
 2011
 8 2 p. 146-
1 p.
 article
130 Intermittent spectrometric fluorescence monitoring for 5-ALA-mediated PDD-PDT using an LED irradiation and a VLD excitation in vivo Yoshida, T.
 2011
 8 2 p. 153-
1 p.
 article
131 Interstitial photodynamic therapy and laser hyperthermia in patients with intradermal metastases of breast cancer Filonenko, E.V.
 2011
 8 2 p. 202-203
2 p.
 article
132 Intracellular localization, pharmacokinetics, biodistribution and PDT efficacy of photostable bacteriochlorins Arnaut, L.
 2011
 8 2 p. 133-134
2 p.
 article
133 Intracellular photodynamic therapy with novel photosensitisers loaded nanoparticule Saydan, N.
 2011
 8 2 p. 209-
1 p.
 article
134 Intraoperative tissue fluorescence using 5-aminolevolinic acid (ALA) is more sensitive than contrast- MRI or amino acid (FET)- PET guided glioblastoma (GBM) surgery Roessler, K.
 2011
 8 2 p. 164-
1 p.
 article
135 Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma Mroz, P.
 2011
 8 2 p. 207-
1 p.
 article
136 Investigation of the ultrashort laser ablation in liver for increased ALA penetration Nicolodelli, G.
 2011
 8 2 p. 199-
1 p.
 article
137 In vitro and in vivo photocytotoxicity of boron dipyrromethene difluoride for photodynamic therapy Lim, S.H.
 2011
 8 2 p. 191-192
2 p.
 article
138 In vitro and in vivo SST2 receptor targeted photodynamic therapy de Bruijn, H.S.
 2011
 8 2 p. 195-
1 p.
 article
139 In vitro investigation for high efficiency PPIX-PDT with nonviral vector, HVJ-E Awazu, K.
 2011
 8 2 p. 205-
1 p.
 article
140 In vitro optimization of antimicrobial photodynamic therapy (aPDT) for eradication of mixed species biofilms representative of chronic rhinosinusitis Gibbs, A.
 2011
 8 2 p. 222-
1 p.
 article
141 In vitro photodynamic efficiency of mTHPC-loaded Lipidots® Creusat, G.
 2011
 8 2 p. 206-
1 p.
 article
142 In vivo detection of PpIX induced by ALA shows no synthesis in dermal Basal Cell Carcinoma Monti, M.
 2011
 8 2 p. 145-
1 p.
 article
143 In vivo light dosimetry for HPPH-mediated pleural PDT—An update Dimofte, A.
 2011
 8 2 p. 199-
1 p.
 article
144 In vivo noninvasive evaluation of basal cell carcinoma response to MAL-PDT by reflectance confocal microscopy Venturini, M.
 2011
 8 2 p. 201-
1 p.
 article
145 In vivo quantification of photosensitizer concentration using optical spectroscopy: Influence of formulation (foscan, foslip, fospeg) and location (liver, lip, tongue) de Visscher, S.
 2011
 8 2 p. 226-
1 p.
 article
146 In vivo real time fluorescence microscopy and single fiber spectroscopy during ALA-PDT van Zaane, F.
 2011
 8 2 p. 199-
1 p.
 article
147 In vivo studies of the pharmacokinetic properties of TPCS2a in a hamster model for photochemical internalisation (PCI) using fibre-optic fluorescence spectroscopy Wang, J.T.-W.
 2011
 8 2 p. 154-
1 p.
 article
148 In vivo toxicological evaluation of magnetite nanoparticles Ali, T.
 2011
 8 2 p. 206-
1 p.
 article
149 IPA Programme Kostron, Herwig
 2011
 8 2 p. 105-106
2 p.
 article
150 Italian dermatological experience on non-melanoma skin cancers (NMSCs) with Temoporfin-PDT Monti, M.
 2011
 8 2 p. 201-202
2 p.
 article
151 Laser related medical trials—Experience with treatment of inoperable oral and maxillofacial tumors with laser photodynamic therapy in small animals Kovacs, K.
 2011
 8 2 p. 139-
1 p.
 article
152 Light distribution in turbid media for photodynamic therapy dosimetry applications: An empirical approach Moriyama, L.T.
 2011
 8 2 p. 199-200
2 p.
 article
153 Light-emitting diode based illumination system for in vitro photodynamic therapy Chen, D.
 2011
 8 2 p. 200-
1 p.
 article
154 Localized photo-oxidative burst stimulates de-novo ROS/RNS generation and apoptosis in bystander cells that propagate radialy through intercellular gap junctions Scherz, A.
 2011
 8 2 p. 150-151
2 p.
 article
155 Longitudinal oral mucosal tissue imaging using co-localised optical coherence tomography and micro-vascular imaging Kowalski, C.
 2011
 8 2 p. 226-
1 p.
 article
156 MAL-PDT off label in Italy Venturini, M.
 2011
 8 2 p. 146-
1 p.
 article
157 Maximising protoporphyrin IX (PpIX) accumulation with the hydroxypyridinone iron chelator CP94 Blake, E.
 2011
 8 2 p. 212-213
2 p.
 article
158 Mechanism-based enhancement of molecular, cellular and stromal therapies by PDT in a 3D model for micrometastatic ovarian cancer Rizvi, I.
 2011
 8 2 p. 135-136
2 p.
 article
159 Mechanisms underlying the accumulation of hypericin in non-muscle invasive bladder cancer de Witte, P.
 2011
 8 2 p. 175-
1 p.
 article
160 Mechanistic studies on the anticancer activity of novel amphiphilic halogenated bacteriochlorins Dabrowski, J.
 2011
 8 2 p. 184-
1 p.
 article
161 Micro-vascularoscopy: A valuable technique for localised optical tissue assessment? Cook, R.J.
 2011
 8 2 p. 227-
1 p.
 article
162 Minimal interventions for vascular anomalies Jerjes, W.
 2011
 8 2 p. 215-
1 p.
 article
163 Model for effects of a broad threshold dose distribution for multi-session of photodynamic therapy Sabino, L.G.
 2011
 8 2 p. 186-
1 p.
 article
164 Model for photodynamic therapy outcome prediction using fluorescence information in vivo Vollet-Filho, J.D.
 2011
 8 2 p. 197-198
2 p.
 article
165 Monitoring mTHPC-mediated PDT of anal intraepithelial neoplasia III van Zaane, F.
 2011
 8 2 p. 174-
1 p.
 article
166 Monitoring photodynamic therapy using quantitative reflectance and fluorescence spectroscopic measurements performed with a single optical fiber Kanick, S.C.
 2011
 8 2 p. 227-
1 p.
 article
167 Mouse strain affects the dynamics of tumor vascular response during PDT Busch, T.
 2011
 8 2 p. 184-
1 p.
 article
168 mTHPC-based biodegradable nanoparticles for cancer treatment Bezdetnaya, L.
 2011
 8 2 p. 156-
1 p.
 article
169 Multi-fluorescence emission from free-base porphyrins Uttamlal, M.
 2011
 8 2 p. 133-
1 p.
 article
170 Multifunctional nanoparticles for brain tumors Frochot, C.
 2011
 8 2 p. 161-
1 p.
 article
171 Multiple excitation autofluorescence spectra for pattern recognition of colonic tissues Liu, L.
 2011
 8 2 p. 204-
1 p.
 article
172 New aspects in singlet oxygen luminescence detection in biological relevant systems Röder, B.
 2011
 8 2 p. 153-
1 p.
 article
173 New intelligent lasers for photodynamic therapy Boucher, D.
 2011
 8 2 p. 143-
1 p.
 article
174 NF-kappaB inhibition improves the sensitivity of human glioblastoma cells to 5-aminolevulinic acid-based photodynamic therapy Piette, J.
 2011
 8 2 p. 165-
1 p.
 article
175 No more secrets in PDT mechanisms? Kessel, D.
 2011
 8 2 p. 125-
1 p.
 article
176 Non-invasive monitoring of dermatological PDT Curnow, A.
 2011
 8 2 p. 144-145
2 p.
 article
177 Non-invasive monitoring of photodynamic therapy of oral cancers by fluorescence differential path-length spectroscopy Karakullukcu, B.
 2011
 8 2 p. 227-228
2 p.
 article
178 Noninvasive oxygen and perfusion measurements in tumors after PDT Krzykawska, M.
 2011
 8 2 p. 185-
1 p.
 article
179 Non-oncological indications for PDT in dermatology Sidoroff, A.
 2011
 8 2 p. 146-
1 p.
 article
180 Non-thermal cardiac ablation with photosensitization reaction in right atrial isthmus of porcine heart Ito, A.
 2011
 8 2 p. 220-
1 p.
 article
181 Novel cationic-charged methylene blue derivatives for antimicrobial PDT Späth, A.
 2011
 8 2 p. 222-223
2 p.
 article
182 Novel optical probes for image-guided tumor resection and photodynamic therapy based on glucose transporters Moriyama, E.
 2011
 8 2 p. 156-
1 p.
 article
183 Optical coherence tomography for classification of oral mucosal lesions Witjes, M.
 2011
 8 2 p. 228-
1 p.
 article
184 Optical coherence tomography-guided photodynamic therapy for skin cancer: Case series Hamdoon, Z.
 2011
 8 2 p. 229-
1 p.
 article
185 Optical coherence tomography in the evaluation of tongue papillae in healthy individuals Hamdoon, Z.
 2011
 8 2 p. 215-
1 p.
 article
186 Optical coherence tomography (OCT) for early diagnosis of tumors and online-control of photodynamic therapy (PDT) Hüttmann, Gereon
 2011
 8 2 p. 152-
1 p.
 article
187 Optical coherence tomography of the tongue papillae for patients suffering from taste disorders following chemoradiotherapy Hamdoon, Z.
 2011
 8 2 p. 230-
1 p.
 article
188 Optical diagnostics: An update on the most commonly applied techniques in the head and neck Jerjes, W.
 2011
 8 2 p. 228-
1 p.
 article
189 Optical property reconstruction for interstitial diffuse optical tomography Liang, X.
 2011
 8 2 p. 144-
1 p.
 article
190 Optimization of a two-photon-activated porphyrin PDT agent incorporating imaging and targeting moieties for the treatment of head and neck cancers Spangler, C.
 2011
 8 2 p. 195-196
2 p.
 article
191 Out-patients based ablative treatment of praecancerous gastrointestinal lesions using ALA/PDT with APC Mlkvy, P.
 2011
 8 2 p. 174-
1 p.
 article
192 Pain during topical photodynamic therapy in Pakistani and Afghani patients Khan, R.U.
 2011
 8 2 p. 145-146
2 p.
 article
193 PDT dosimetry: Easy-as-pie or pie-in-the-sky? Patterson, M.
 2011
 8 2 p. 140-
1 p.
 article
194 PDT dosimetry with porphyrin precursors Robinson, D.
 2011
 8 2 p. 148-
1 p.
 article
195 PDT effect on Pythiosis—In vitro and in vivo investigation Pires, L.
 2011
 8 2 p. 223-
1 p.
 article
196 PDT for basal cell carcinoma of the nose Allan, E.
 2011
 8 2 p. 145-
1 p.
 article
197 PDT for drug delivery van den Bergh, H.
 2011
 8 2 p. 127-
1 p.
 article
198 PDT for Vulval Intraepithelial Neoplasia (VIN): Results of pilot study; lesson learned Poole, D.
 2011
 8 2 p. 169-170
2 p.
 article
199 PDT in dermatology–A success story Sidoroff, A.
 2011
 8 2 p. 124-
1 p.
 article
200 PDT in oral diseases of microbial origin: The challenge of oral biofilm Nunez, S.
 2011
 8 2 p. 178-179
2 p.
 article
201 PDT in the oesophagus Bown, S.
 2011
 8 2 p. 171-
1 p.
 article
202 PDT of brain tumours: Tipping points Eljamel, S.
 2011
 8 2 p. 125-
1 p.
 article
203 PDT, the treatment of choice for elderly patients with superficial tumors of moderate/big dimensions and/or aktinic keratosis Alberdi, E.
 2011
 8 2 p. 202-
1 p.
 article
204 PDT using ultrashort pulses—Investigation of induced necrosis Grecco, C.
 2011
 8 2 p. 185-
1 p.
 article
205 PEGylated liposomes, PLGA or ORMOSIL nanoparticles for the delivery of mTHPC to cancer cells Moret, F.
 2011
 8 2 p. 155-
1 p.
 article
206 PEGylated poly(lactide-co-glycolide) nanoparticles loaded with meta-tetra(hydroxyphenyl)chlorin for photodynamic treatment of cancer Moret, F.
 2011
 8 2 p. 159-
1 p.
 article
207 Peptide-conjugated nanoparticles for photodynamic therapy targeting neuropilin-1 Bechet, D.
 2011
 8 2 p. 207-
1 p.
 article
208 Phenytoin treatment reduce 5-ALA induced PpIX accumulation Albert, I.
 2011
 8 2 p. 213-214
2 p.
 article
209 Pheophytin a and b mediated photodynamic therapy against sensitive and multidrug-resistant breast cancer cells Li, W.-T.
 2011
 8 2 p. 130-
1 p.
 article
210 Photobleaching-based method to individualize irradiation time during interstitial photodynamic therapy Hennig, G.
 2011
 8 2 p. 143-144
2 p.
 article
211 Photochemical internalization (PCI), a technology for site-specific drug delivery. Recent advances Berg, Kristian
 2011
 8 2 p. 156-
1 p.
 article
212 Photodiagnosis and photodynamic therapy for ovarian cancer treatment Mordon, S.
 2011
 8 2 p. 170-
1 p.
 article
213 Photodynamic antimicrobial therapy associated with surgical endodontic treatment Garcez, A.S.
 2011
 8 2 p. 181-
1 p.
 article
214 Photodynamic applications in neurosurgery Kaneko, S.
 2011
 8 2 p. 161-
1 p.
 article
215 Photodynamic effect in vitro of hypericin on yeasts and evaluation of its photocytotoxicity in keratinocytes and fibroblasts Agut, M.
 2011
 8 2 p. 224-
1 p.
 article
216 Photodynamic effect of novel octaphosphante porphyrin evaluated by Raman spectroscopy and fluorescence microscopy Jayasree, R.S.
 2011
 8 2 p. 192-
1 p.
 article
217 Photodynamic inactivation enhanced by special biomaterial on methicillin-resistant Staphylococcus aureus Tseng, S.-P.
 2011
 8 2 p. 224-
1 p.
 article
218 Photodynamic Inactivation of Staphylococcus aureus using a water-soluble formulation of curcumin as photosensitizer Winter, S.
 2011
 8 2 p. 223-
1 p.
 article
219 Photodynamic therapy and fluorescent diagnostics in Russian Federation: Experimental and clinical results Vakulovskaya, E.
 2011
 8 2 p. 183-
1 p.
 article
220 Photodynamic therapy and photodynamic diagnosis in Korea Ahn, W.S.
 2011
 8 2 p. 183-
1 p.
 article
221 Photodynamic therapy and the suppression of tumor angiogenesis by monoclonal antibodies to improve treatment response Bhuvaneswari, R.
 2011
 8 2 p. 136-137
2 p.
 article
222 Photodynamic therapy and the treatment of head and neck malignancies Biel, M.
 2011
 8 2 p. 166-167
2 p.
 article
223 Photodynamic therapy combined with bevacizumab injection for the treatment of pterygium Mamikonyan, V.
 2011
 8 2 p. 225-
1 p.
 article
224 Photodynamic therapy downregulates matrix metalloproteinases in oral carcinoma Biel, M.
 2011
 8 2 p. 128-
1 p.
 article
225 Photodynamic therapy for cholangiocarcinoma by percutaneous transhepatic access Lasarev, S.M.
 2011
 8 2 p. 220-
1 p.
 article
226 Photodynamic therapy for hilar cholangiocarcinoma Shim, C.S.
 2011
 8 2 p. 218-219
2 p.
 article
227 Photodynamic therapy for lung and esophageal cancer: A review of outcomes at a single comprehensive cancer center Ross, P.
 2011
 8 2 p. 176-177
2 p.
 article
228 Photodynamic therapy for precancer and early stage cancer of the uterine cervix with fertility preservation Sakamoto, M.
 2011
 8 2 p. 218-
1 p.
 article
229 Photodynamic therapy for tracheobronchial cancer Jheon, S.
 2011
 8 2 p. 177-
1 p.
 article
230 Photodynamic therapy in gastrointestinal tumor patients Jeon, W.K.
 2011
 8 2 p. 172-
1 p.
 article
231 Photodynamic therapy in the management of pre-malignant head and neck mucosal dysplasia and microinvasive carcinoma Quon, Harry
 2011
 8 2 p. 75-85
11 p.
 article
232 Photodynamic therapy in the multimodality management of lung and pleural malignancies Cengel, K.
 2011
 8 2 p. 176-
1 p.
 article
233 Photodynamic therapy in the treatment of oral cancer with Photolon: An analysis of 51 cases Polkin, V.
 2011
 8 2 p. 168-
1 p.
 article
234 Photodynamic therapy of cervical condylomata acuminata Wang, X.L.
 2011
 8 2 p. 169-
1 p.
 article
235 Photodynamic Therapy of trachea and main bronchi cancer employing the photodynamic action of the photosensitisers of second generation Shafirovskiy, B.B.
 2011
 8 2 p. 220-
1 p.
 article
236 Photodynamic therapy of tumors can lead to development of systemic antigen-specific immune response Mroz, P.
 2011
 8 2 p. 131-
1 p.
 article
237 Photodynamic therapy of vulvar pointed condyloma in women Apolikhina, I.A.
 2011
 8 2 p. 216-
1 p.
 article
238 Photodynamic therapy outcome for skin pathologies: A single institute experience Jerjes, W.
 2011
 8 2 p. 145-
1 p.
 article
239 Photodynamic therapy using Photosens for the treatment of chronic central serous chorioretinopathy Schegoleva, I.
 2011
 8 2 p. 225-
1 p.
 article
240 Photodynamic therapy with silicon nanoparticles Douplik, A.
 2011
 8 2 p. 207-
1 p.
 article
241 Photodynamic treatment for the selective depletion of circulating tumor cells in human mononuclear cell-enriched blood preparations Ziegler, V.G.
 2011
 8 2 p. 138-
1 p.
 article
242 Photodynamic treatment of a malignant peripheral nerve sheeth tumor (MPNST) of the scull base: A case report Kostron, H.
 2011
 8 2 p. 210-
1 p.
 article
243 Photofrin-PDT for upper gastrointestinal cancers Nishiwaki, Y.
 2011
 8 2 p. 172-
1 p.
 article
244 Photofrin photosensitizer inhibits the expression of EGFR independent of light irradiation in cancer cells Yang, P.-W.
 2011
 8 2 p. 128-
1 p.
 article
245 Photophysical and biological studies of zinc(ii) phthalocyanine derivatives Tominaga, T.T.
 2011
 8 2 p. 192-
1 p.
 article
246 Photophysical characteristics of the porphyrine XF73 and singlet oxygen luminescence in cells Felgenträger, A.
 2011
 8 2 p. 154-
1 p.
 article
247 Photosensitiser-nanoparticle conjugates for targeted PDT Russell, D.
 2011
 8 2 p. 158-
1 p.
 article
248 Photosens PDT at the treatment of virus-associated precancer and non-invasive cervical cancer Trushina, O.
 2011
 8 2 p. 217-
1 p.
 article
249 Photo-toxic effects of near-infrared light irradiation with indocyanine green on rat mammary adenocarcinoma cells Funayama, T.
 2011
 8 2 p. 188-
1 p.
 article
250 Place of cryotherapy, argon plasma coagulation? Photodynamic therapy and stents in therapeutic bronchoscopy of lung cancers Hongwu, W.
 2011
 8 2 p. 176-
1 p.
 article
251 Polyacrylamide nanoparticle platform for PET/fluorescence imaging and therapy Gupta, A.
 2011
 8 2 p. 154-155
2 p.
 article
252 Polymeric nanoparticles as an efficient delivery system for phthalocyanine based photosensitizers in photodynamic therapy (PDT) Celik, A.
 2011
 8 2 p. 206-
1 p.
 article
253 Porphycene–apidaecin conjugate: A new broad spectrum antimicrobial agent Dosselli, R.
 2011
 8 2 p. 225-
1 p.
 article
254 Possibilities of improving activity of antimicrobial photodynamic therapy Kasimova, K.R.
 2011
 8 2 p. 182-183
2 p.
 article
255 Potential cancer diagnosis via porphyrin determination following administration of 5-aminolevulinic acid (ALA) Ishizuka, M.
 2011
 8 2 p. 153-154
2 p.
 article
256 Potential of PDT for the treatment of diseases caused by parasitic and free-living protozoa Coppellotti, O.
 2011
 8 2 p. 178-
1 p.
 article
257 Potential sensitizers for two-photon photodynamic therapy Timofeeva, T.
 2011
 8 2 p. 198-
1 p.
 article
258 Prevention of severe photosensitivity after m-THPC IPDT with a natural antioxidant agent Petri, A.
 2011
 8 2 p. 203-
1 p.
 article
259 Preventive effect of ALA-PDT on UV radiation-induced skin carcinoma ¿C in vivo study in a mouse model Wang, X.L.
 2011
 8 2 p. 151-152
2 p.
 article
260 Protoporphyrin IX kinetics for interstitial photodynamic therapy dosimetry of malignant glioma Beyer, W.
 2011
 8 2 p. 210-211
2 p.
 article
261 Protoporphyrin IX production and photobleaching during treatment of condyloma by HPV with methyl aminolevulinate Inada, N.
 2011
 8 2 p. 216-217
2 p.
 article
262 Qualitative optical coherence tomography for normal and pathologic skin lesions Hamdoon, Z.
 2011
 8 2 p. 228-229
2 p.
 article
263 Quantitative Imaging of Photodynamic Therapy and Gemcitabine Combination Treatment Response in 3D Pancreatic Tumor Models Celli, J.P.
 2011
 8 2 p. 171-172
2 p.
 article
264 Quantitative measurement of photodynamic diagnoses of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins Maruyama, T.
 2011
 8 2 p. 162-163
2 p.
 article
265 Quantitative measurements of ALA-induced PpIX during brain tumor resection Wilson, B.
 2011
 8 2 p. 162-
1 p.
 article
266 Quantitative, multi-scale fluorescence imaging reveals rapid tumor permeation and intracellular delivery of liposome-associated bevacizumab Spring, B.
 2011
 8 2 p. 196-
1 p.
 article
267 Quantitative PDT dose reponses in vivo Wilson, B.
 2011
 8 2 p. 141-
1 p.
 article
268 Reactive oxygen species generation from photoexcited quantum dot nanoparticles: Type I versus Type II photochemical mechanism Yaghini, E.
 2011
 8 2 p. 151-
1 p.
 article
269 Reduction of endotracheal tube biofilms using antimicrobial photodynamic therapy Biel, M.
 2011
 8 2 p. 179-
1 p.
 article
270 Results of intraoperative photodynamic therapy in complex with the fluorescent diagnostics to treat the brain metastasis Chissov, V.I.
 2011
 8 2 p. 211-
1 p.
 article
271 Rgeioselective bromination of chlorins and bacteriochlorins: A key approach for developing multifunctional agents for tumor imaging and photodynamic therapy Ethirajan, M.
 2011
 8 2 p. 192-193
2 p.
 article
272 Risk assessment of oral epithelium thickness using in vivo OCT Hamdoon, Z.
 2011
 8 2 p. 229-230
2 p.
 article
273 Secondary ROS or peroxides after singlet oxygen production Lhommeau, I.
 2011
 8 2 p. 151-
1 p.
 article
274 Selective antitumor effect in photodynamic therapy mediated by photo-activable molecules, activated by endopeptidases Verhille, M.
 2011
 8 2 p. 136-
1 p.
 article
275 Sensitivity of Staphylococcus aureus strains to photoinactivation Grinholc, M.
 2011
 8 2 p. 222-
1 p.
 article
276 Simultaneous intraoperative diagnosis and photodynamic therapy for malignant brain tumors: The concept “to see and to treat” Kostron, H.
 2011
 8 2 p. 161-162
2 p.
 article
277 Single fiber reflectance measurements of cervical lymph nodes for identifying metastasis from oral carcinoma Witjes, M.
 2011
 8 2 p. 229-
1 p.
 article
278 Singlet oxygen dosimetry modeling for photodynamic therapy Liang, X.
 2011
 8 2 p. 142-
1 p.
 article
279 Singlet oxygen in photodynamic therapy and beyond: Production and detection Nonell, S.
 2011
 8 2 p. 150-
1 p.
 article
280 Size that matters (for the delivery of photosensitizers) Lange, N.
 2011
 8 2 p. 155-
1 p.
 article
281 Skin PDT: Introducing superficial fibre optic reflectance spectroscopy to monitor blood volume and saturation Middelburg, T.A.
 2011
 8 2 p. 147-
1 p.
 article
282 Sonodynamic therapy enhance Photolon-mediated photodynamic therapy of rat brain tumor model glioma C6 Tzerkovsky, D.
 2011
 8 2 p. 164-
1 p.
 article
283 Squaraine dyes as PDT sensitizers: Specific functionalization for biological targeting Ronchi, E.
 2011
 8 2 p. 193-
1 p.
 article
284 Strategies to enhance drug delivery and targeting in photodynamic therapy to improve treatment outcome Olivo, M.
 2011
 8 2 p. 158-
1 p.
 article
285 Strong 5-aminolevulinic acid induced flourescence is an intraoperative marker for representative tissue samples in stereotactic tumor biopsies Widhalm, G.
 2011
 8 2 p. 163-
1 p.
 article
286 Structure–photodynamic activity relationships of sulfonated phthalocyanine analyzed by positron emission tomography (FDG-PET) in real time van Lier, J.E.
 2011
 8 2 p. 133-
1 p.
 article
287 Study on the interaction between photodynamic therapy and a PI3K pathway inhibitor Chen, B.
 2011
 8 2 p. 186-187
2 p.
 article
288 Synergy of photodynamic vascular damage in combination with anti-angiogenic tyrosine kinase inhibitors Nowak-Sliwinska, P.
 2011
 8 2 p. 135-
1 p.
 article
289 Synthesis and characterization of chlorin based anticancer drug conjugate Battogtokh, G.
 2011
 8 2 p. 131-
1 p.
 article
290 Synthesis and characterization of gold nanoparticles based on water-soluble Purpurin-18-N-methyl-d-glucamine Byambajav, Lkhagvadulam
 2011
 8 2 p. 209-
1 p.
 article
291 Synthesis and characterization of porphyrin-patterned superparamagnetic nanoparticles: Application for nanophotodynamic therapy (NPDT) of cancer Mbakidi, J.-P.
 2011
 8 2 p. 208-
1 p.
 article
292 Synthesis and characterization of tumor targeted multifunctional agents for photodynamic therapy, MR and optical imaging White, W.H.
 2011
 8 2 p. 132-
1 p.
 article
293 Synthesis and physico-chemical properties of BODIPY dyes, a new class of photosensitizers Zaza, S.
 2011
 8 2 p. 194-
1 p.
 article
294 Synthesis of chlorin-based fatty acid conjugate as photosensitizer for photodynamic therapy Ansari, S.A.
 2011
 8 2 p. 194-
1 p.
 article
295 Synthesis of dextran/Fe3O4 nanoparticles for thermolysing oral cancer Lee, S.S.
 2011
 8 2 p. 208-209
2 p.
 article
296 Synthesis of phthalocyanines (Pcs) for photodynamic therapy (PDT) Moussaron, A.
 2011
 8 2 p. 193-194
2 p.
 article
297 Targeted PDT and its clinical relevance Hasan, T.
 2011
 8 2 p. 123-
1 p.
 article
298 Targeted PDT with phthalocyanine nanoparticles Kogan, B.
 2011
 8 2 p. 209-
1 p.
 article
299 Temocene: The porphycene analogue of temoporfin (Foscan®) Garcia-Diaz, M.
 2011
 8 2 p. 132-
1 p.
 article
300 Temoporfin and its liposomal formulations Foslip and Fospeg—Properties and behaviour Scheglmann, D.
 2011
 8 2 p. 195-
1 p.
 article
301 Temoporfin PDT partial response of multiple head-and-neck skin epitheliomas: Implication of warfarin Monti, M.
 2011
 8 2 p. 202-
1 p.
 article
302 The cases of Concurrent Chemo-Photodynamic therapy (CCPDT) for the uterine endometrial cancer in young women desiring fertility T.G.Ahn,
 2011
 8 2 p. 217-
1 p.
 article
303 The clinical experiences of Concurrent Chemo-Photodynamic Therapy (CCPDT) in the uterine cervical cancer staged 1B1 and 1B2, especially young women desiring fertility Ahn, T.G.
 2011
 8 2 p. 217-
1 p.
 article
304 The history of photodynamic therapy in Innsbruck Kostron, H.
 2011
 8 2 p. 210-
1 p.
 article
305 The influence of bulk optical properties on photosensitizer quantification using an ultrasound-guided fluorescence tomography instrument Axelsson, J.
 2011
 8 2 p. 143-
1 p.
 article
306 The interaction of PDT with other novel therapies of malignant gliomas Eljamel, S.
 2011
 8 2 p. 165-
1 p.
 article
307 The management of periorbital skin tumours using surface illumination photodynamic therapy: Case series Jerjes, W.
 2011
 8 2 p. 229-
1 p.
 article
308 The measurement of porphyrin following administration of 5-aminolevulinic acid in dogs with tumor Osaki, T.
 2011
 8 2 p. 140-
1 p.
 article
309 The proliferation marker Ki-67 as novel molecular target for PDT Rahmanzadeh, R.
 2011
 8 2 p. 129-
1 p.
 article
310 Therapeutic effects of systemic PDT in a leukemia animal model using A20 cell lines Wen, L.Y.
 2011
 8 2 p. 137-
1 p.
 article
311 The role of autofluorescence endoscopy in non-malignant esophageal diseases Latos, W.
 2011
 8 2 p. 173-
1 p.
 article
312 The role of photodynamic therapy in multidisciplinary oncological care Jerjes, W.
 2011
 8 2 p. 215-
1 p.
 article
313 The role of singlet oxygen in PDT Moan, J.
 2011
 8 2 p. 147-148
2 p.
 article
314 The roles heme oxygenase-1 in activation of cellular rescue mechanism during PDT oxidative stress and cell death protection Malik, Z.
 2011
 8 2 p. 127-
1 p.
 article
315 The use of psoralen plus Ultra Violet A (UVA) as a new candidate for the treatment of superficial bladder cancer Pooya, M.
 2011
 8 2 p. 175-176
2 p.
 article
316 The value of 5-aminolevulinic acid induced fluorescence for resection of diffusely infiltrating gliomas Wolfsberger, S.
 2011
 8 2 p. 163-164
2 p.
 article
317 The versatility of polyacrylamide nanoparticles for developing efficient multifunctional nanoplatform for tumor-imaging and phototherapy Pandey, R.
 2011
 8 2 p. 131-
1 p.
 article
318 TPCS2a based bleomycin photochemical internalization in normal hamster cheek pouch Sultan, A.A.
 2011
 8 2 p. 187-
1 p.
 article
319 Treatment of acne: Photodynamic therapy and micropeeling Monti, M.
 2011
 8 2 p. 202-
1 p.
 article
320 Treatment of spontaneous piodermitis in dogs by PDT using porphyrin-type photosensitisers Fabris, C.
 2011
 8 2 p. 138-
1 p.
 article
321 Tricationic porphycene derivative Py3MeO–TBPo mediated photodynamic effects on tumour HeLa cells Acedo, P.
 2011
 8 2 p. 187-
1 p.
 article
322 Tumor selectivity and photodynamic treatment efficacy of chlorin p6-histamine conjugate in Hamster cheek pouch tumor model Parihar, A.
 2011
 8 2 p. 196-
1 p.
 article
323 Tumour selectivity in a phase I clinical trial of photochemical internalization with PC-A11 (Amphinex® +bleomycin) Sultan, A.A.
 2011
 8 2 p. 197-
1 p.
 article
324 Ultra low fluence rate PTD study on glioma and glia cells Su, C.-M.
 2011
 8 2 p. 211-
1 p.
 article
325 Up-converting NaxLiyYF4:Yb3+, Er3+ nanocrystals functionalized with protoporphyrin IX as a potential drug in photodynamic therapy for cancer treatment Stuchinskaya, T.
 2011
 8 2 p. 159-
1 p.
 article
326 Using lipidots® as nanocarrier to improve PDT efficiency Thomann, J.-S.
 2011
 8 2 p. 160-
1 p.
 article
327 Vacataporphyrin, a new sensitizer for photodynamic therapy: An in vitro study Zilkowski, P.
 2011
 8 2 p. 134-
1 p.
 article
328 Vascular effect of photodynamic therapy using a chorioallantoic membrane model Buzza, H.
 2011
 8 2 p. 188-
1 p.
 article
329 Vitamin D pretreatment augments aminolevulinate photodynamic therapy-induced cell death by upregulation of tumor necrosis factor alpha and caspase-8 in mouse models of skin carcinoma Anand, S.
 2011
 8 2 p. 129-
1 p.
 article
330 Where does PDT fit in within the range of treatment methods for oesophageal cancer: A 35 years experience and review of literature Moghissi, K.
 2011
 8 2 p. 173-
1 p.
 article
331 Why use nanoparticles as photosensitizers for PDT? Kopelman, R.
 2011
 8 2 p. 157-158
2 p.
 article
                             331 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands